It was estimated that approximately 30% of human lung cancers acquire mutations of the Nrf2 signaling genes, including Keap1 and Nfe2l2 that encodes Nrf2 protein, which leads to a stabilization and sustained activation of Nrf2 27. The gene discussed is KEAP1; the disease is lung carcinoma.